Browsing by Author Zeller, Tanja

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2015Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker studyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Nestel, P; Stewart, Ralph; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey; Zeller, Tanja; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBiomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study, International Journal of Cardiology, vol.201, N/A, 2015,pp 499-507
2013Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyBarnes, Elizabeth; Keech, Anthony (Tony); Marschner, Ian (Colin); Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreChanges in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study, Journal of the American Heart Association, vol.2, 5, 2013,pp 1-12
2013Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconusMitchell, Paul; Wang, Jie Jin; Burdon, Kathryn P; Bykhovskaya, Yelena; et al, Various; Hewitt, Alex; Hysi, Pirro G.; Khor, Chiea Chuen; Koehn, Demelza; Lu, Yi; Misshahi, Alireza; Ramdas, Wishal; Vitart, Veronique; Zeller, Tanja; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteGenome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus, Nature Genetics, vol.45, 2, 2013,pp 155-163
2014High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish CohortWoodward, Mark; Blankenberg, Stefan; Hughes, Maria; Kee, Frank; Kuulasmaa, Kari; Ojeda, Francisco; Saarela, Olli; Salomaa, Veikko; Schnabel, Renate; Struthers, Allan; Tunstall-Pedoe, Hugh; Tuovinen, Tarja; Zeller, Tanja; The George Institute for Global HealthHigh population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort, European Heart Journal, vol.35, 5, 2014,pp 271-281
2014Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyMann, Kristy; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Sydow, Karsten; Tonkin, Andrew M; West, Malcolm; White, Harvey; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMidregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study, International Journal of Cardiology, vol.172, 2, 2014,pp 411-418